Brazil’s Bolsonaro says he will not be vaccinated against coronavirus in Latin America


The right-wing leader adds that Congress was not likely to be vaccinated by the Brazilian people.

Brazilian President Jar Bolsonaro said on Thursday evening that he would not take the coronavirus vaccine, adding that he doubted vaccination programs would end the epidemic with high hopes.

In live broadcast statements on multiple social media platforms, the right-wing leader added that Congress is unlikely to be vaccinated by the Brazilian people.

Brazil has the second highest number of coronavirus deaths, and for months, Bolsonaro has been watching the severity of the epidemic despite being diagnosed with the virus in July.

“I tell you, I am not going to take it. That is my right, “he said.

Many countries around the world have made masks mandatory in public, and the WHO has said that masks should be worn in public areas where there is a risk of widespread community transition and physical distance is difficult, such as on public transport, in shops or other closed settings.

In his recent comments, Bolsonaro expressed skepticism about the effectiveness of wearing a mask, meaning that there is not much conclusive evidence to prevent the transmission of the mask virus.

Scientists have shown that the mask prevents droplets and aerosols from entering the air, while the U.S. Department of Disease Control and Prevention The centers emphasize their importance in preventing the spread of the disease by people who do not have symptoms and do not know they have the virus. .

The president has repeatedly said that when the coronavirus vaccine becomes widely available, the people of Brazil will not need to be vaccinated.

In October, he joked on Twitter that vaccination was only necessary for his dog.

He has also appealed to the untrained anti-malarial hydroxychloroquine as a treatment for the virus and said he took the drug in July when he was diagnosed with Covid-19.

The same month the WHO dropped hydroxychloroquine from its large-scale treatment trial because it did not reduce mortality among those being treated for the disease in hospitals.

.